Paper402107
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
Sammons ML and 4 others. Antimicrob Agents Chemother, 1977. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex. Papers, record 402107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/402107
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Poly I-C | Major topic |
| Animals | |
| Carboxymethylcellulose Sodium | |
| Haplorhini | |
| Injections, Intravenous | |
| Macaca fascicularis | |
| Macaca mulatta | |
| Male | |
| Polylysine |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4344367 | Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents. | Infect Immun | 1972 | https://conductscience.org/library/papers/4344367 | PubMed |
| 2 | 4630165 | Studies on poly I:C toxicity in experimental animals. | Toxicol Appl Pharmacol | 1972 | https://conductscience.org/library/papers/4630165 | PubMed |
| 3 | 4334380 | Evaluation of an interferon inducer in viral respiratory disease. | JAMA | 1972 | https://conductscience.org/library/papers/4334380 | PubMed |
| 4 | 4325022 | Semi-micro, dye-binding assay for rabbit interferon. | Appl Microbiol | 1971 | https://conductscience.org/library/papers/4325022 | PubMed |
| 5 | 810520 | A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. | J Infect Dis | 1975 | https://conductscience.org/library/papers/810520 | PubMed |
| 6 | 1112978 | The interferon refractory state. II. Biological characterization of a refractoriness-inducing protein. | J Immunol | 1975 | https://conductscience.org/library/papers/1112978 | PubMed |
| 7 | 4338331 | The effect of interferon, interferon inducers or interferon induced virus resistance on subsequent interferon production. | J Gen Virol | 1972 | https://conductscience.org/library/papers/4338331 | PubMed |
| 8 | 5544469 | Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. | Proc Soc Exp Biol Med | 1971 | https://conductscience.org/library/papers/5544469 | PubMed |
| 9 | 5543705 | The interferon refractory state: in vivo and in vitro studies of its mechanism. | J Immunol | 1971 | https://conductscience.org/library/papers/5543705 | PubMed |
| 10 | 5541209 | Polyriboinosinic-polyribocytidylic acid-induced interferons in calves. | Am J Vet Res | 1971 | https://conductscience.org/library/papers/5541209 | PubMed |
| 11 | 5479996 | Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice. | Proc Soc Exp Biol Med | 1970 | https://conductscience.org/library/papers/5479996 | PubMed |
| 12 | 5461121 | Inhibition of biologic activity of poly I: poly C by human plasma. | Proc Soc Exp Biol Med | 1970 | https://conductscience.org/library/papers/5461121 | PubMed |
| 13 | 5836039 | Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor. | Proc Soc Exp Biol Med | 1965 | https://conductscience.org/library/papers/5836039 | PubMed |
| 14 | 5233831 | Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. | Proc Natl Acad Sci U S A | 1967 | https://conductscience.org/library/papers/5233831 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34066908 | Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34066908 | PubMed |
| 33681722 | Nucleic Acid Immunotherapeutics for Cancer. | ACS Appl Bio Mater | 2020 | https://conductscience.org/library/papers/33681722 | PubMed |
| 29696308 | Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/29696308 | PubMed |
| 25746173 | The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014. | Antiviral Res | 2015 | https://conductscience.org/library/papers/25746173 | PubMed |
| 24586996 | Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. | PLoS One | 2014 | https://conductscience.org/library/papers/24586996 | PubMed |
| 19360120 | Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. | PLoS Pathog | 2009 | https://conductscience.org/library/papers/19360120 | PubMed |
| 11291838 | Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group. | Invest New Drugs | 2001 | https://conductscience.org/library/papers/11291838 | PubMed |
| 7352750 | Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7352750 | PubMed |
| 6253403 | Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus. | Infect Immun | 1980 | https://conductscience.org/library/papers/6253403 | PubMed |
| 6158914 | Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6158914 | PubMed |
| 921256 | Systemic metabolic alterations associated with repeated injections of a modified polyriboinosinic-polyribocytidylic acid complex. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/921256 | PubMed |
| 110688 | Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine. | Infect Immun | 1979 | https://conductscience.org/library/papers/110688 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/402107
GET https://conductscience.org/api/papers/v1/402107/authors